Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 1996

View Archived Issues

New agents for CNS disorders claimed by HHS

Beiersdorf-Lilly claims angiotensin II blockers

New cephalosporins from LG Chemical

Dual-action compounds with antiasthma activity reported by Kowa

Medarex claims bispecific reagents for AIDS therapy

British researchers describe anticytokine antisense peptides

Company Profile: Celgene Corporation

Company Profile: Connective Therapeutics

Company Profile: MorphoSys

Company Profile: Shaman Pharmaceuticals

LJP licenses rights to drug for lupus

Further approval for breakthrough glaucoma medication

Andrx licenses chemoprotective agent to Asta

First phase II results for Innapharma's peptide antidepressant

European approval recommended for CMV retinitis Rx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...